Biden Administration's Plan to Address Medicine Shortages

By
Alessandro Rossi
1 min read

The Biden administration has proposed a multibillion-dollar plan to address widespread shortages of drugs, particularly those used in treating cancer and other diseases. The plan entails hospitals paying more for reliable supplies of high-quality medicines, a move aimed at pressuring the market to ensure consistent and dependable access for Americans. US health officials presented this plan to congressional leaders, emphasizing the need for legislation to establish standards for hospitals' medication procurement, especially essential generic drugs. Estimated to cost around $5.11 billion over a decade, this initiative seeks to improve the availability of critical medicines. It signals an effort to prevent potential shortages and enhance the overall quality and reliability of medical supplies, addressing a pressing concern in healthcare.

This article is submitted by our user under the News Submission Rules and Guidelines.The cover photo is computer generated art for illustrative purposes only; not indicative of factual content.

Subscribe to our Newsletter

Get the latest in enterprise business and tech with exclusive peeks at our new offerings